Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial-Reference-Cited by-同舟云学术

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

Published:2016-12 Issue:10062 Volume:388 Page:2895-2903
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Teerlink John R,Felker G Michael,McMurray John J V,Solomon Scott D,Adams Kirkwood F,Cleland John G F,Ezekowitz Justin A,Goudev Assen,Macdonald Peter,Metra Marco,Mitrovic Veselin,Ponikowski Piotr,Serpytis Pranas,Spinar Jindrich,Tomcsányi János,Vandekerckhove Hans J,Voors Adriaan A,Monsalvo Maria Laura,Johnston James,Malik Fady I,Honarpour Narimon

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Mechanisms of contraction of the normal and failing heart;Braunwald;N Engl J Med,1967

2. The search for the ideal positive inotropic agent;Packer;N Engl J Med,1993

3. Cardiac inotropes: current agents and future directions;Hasenfuss;Eur Heart J,2011

4. Cardiac myosin activation: a potential therapeutic approach for systolic heart failure;Malik;Science,2011

5. Improvement of cardiac function by a cardiac myosin activator in conscious dogs with systolic heart failure;Shen;Circ Heart Fail,2010

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myosin Isoform-Dependent Effect of Omecamtiv Mecarbil on the Regulation of Force Generation in Human Cardiac Muscle;International Journal of Molecular Sciences;2024-09-10

2. Association between cardiac time intervals and incident heart failure after acute coronary syndrome;The International Journal of Cardiovascular Imaging;2024-08-03

3. Efficacy and Safety of Omecamtiv Mecarbil in Adult Patients with Heart Failure with Reduced Ejection Fraction;International Journal of Pharmacology;2024-08-01

4. Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium;Heart Failure Reviews;2024-06-29

5. Pharmacological and Non-Pharmacological Advancements in Heart Failure Treatment;Reviews in Cardiovascular Medicine;2024-06-25